Imagen de Portada

The Predictive Value of Quantitative Flow Ratio and Its Derived Angiographic Microvascular Resistance for Restenosis Following Drug‐Coated Balloon Angioplasty

Fuente: Wiley Open Access

Guardado en:

Detalles Bibliográficos
Autores principales:	Chenhang Wang, Li Chen, Xiaoyong Xu
Formato:	Artículo Open Access
Publicado:	Wiley 2025
Materias:	Catheterization and Cardiovascular Interventions
Acceso en línea:	Acceder al recurso
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Prognostic Value of Computational Pressure‐Flow Dynamics Derived FFR Measured Immediately After Successful Paclitaxel‑Coated Balloon Angioplasty for In‐Stent Restenosis Lesion
por: Wangwei Yang, et al.
Publicado: (2026)

Coronary Angiography‐Derived Murray Law‐Based Quantitative Flow Ratio (μQFR) After De Novo Drug‐Coated Balloon Angioplasty
por: Dorian Garin, et al.
Publicado: (2025)

Three‐Year Outcome of Drug Coated Balloon Angioplasty Following Atherectomy for Severely Calcified Coronary Lesions
por: Taka‐aki Takamura, et al.
Publicado: (2025)

Scaffold Versus Repeat Drug‐Coated Balloon Therapy for Early and Late Drug‐Coated Balloon Restenosis in Femoropopliteal Arteries: Results of the RECURRENCE‐2 Study
por: Takashi Yanagiuchi, et al.
Publicado: (2025)

Physiologic Assessment Using Angiography‐Derived Fractional Flow Reserve After Drug‐Coated Balloon Angioplasty in De Novo Coronary Lesions
por: Chun‐Chin Chang, et al.
Publicado: (2026)

Drug‐Coated Balloons in Coronary Artery Disease: Engineering, Pharmacology, and the Mechanisms Behind Angiographic Outcomes
por: Marcello Marchetta, et al.
Publicado: (2026)

Long‐Term Clinical Impact of Successful Vessel Preparation in Femoropopliteal Drug‐Coated Balloon Angioplasty
por: Yusuke Tomoi, et al.
Publicado: (2025)

Prognostic Significance of Bailout Stenting for Residual Stenosis or Dissection Following Drug‐Coated Balloon Angioplasty: A Sub‐Analysis of the EASTBOURNE Study
por: Filippo Luca Gurgoglione, et al.
Publicado: (2025)

Enhanced Drug Effect With Cutting Balloon Followed by Drug Coated Balloon in a Rabbit Model
por: Manabu Shiozaki, et al.
Publicado: (2025)

The Clinical Outcome of Drug‐Coated Balloon Following Jetstream and Drug‐Coated Balloon for Femoropopliteal Nodular Calcification Lesions: The Results of the Multicenter ORION Study
por: Kenji Ogata, et al.
Publicado: (2026)

Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis
por: Vinícius M. R. Oliveira, et al.
Publicado: (2025)

One‐Year Outcomes of Drug‐Coated Balloon Angioplasty With and Without the Blades‐Up Function of the JETSTREAM Atherectomy Device in Femoropopliteal Calcified Lesions
por: Tatsuro Takei, et al.
Publicado: (2026)

Critique on “Paclitaxel‐Coated Balloon for the Management of In‐Stent Coronary Restenosis: An Updated Meta‐Analysis and Trial Sequential Analysis”
por: Emaan Sadiq
Publicado: (2025)

Efficacy and Safety of Sirolimus‐Coated Balloon Angioplasty in De Novo Lesions in Large Coronary Vessels: A Propensity Score‐Matched Study
por: Cecilia Gobbi, et al.
Publicado: (2025)

Drug‐Coated Balloons Versus Non‐Coated Balloons for Side Branch Treatment in Bifurcation Lesions: A Systematic Review and Meta‐Analysis
por: Matteo Rocchetti, et al.
Publicado: (2025)

Ballooned Out the Clot‐Rescue Balloon Pulmonary Angioplasty in a Young Male Presenting With Acute on Chronic Thromboembolic Pulmonary Hypertension
por: Goutam Kintada, et al.
Publicado: (2025)

Impact of Intra‐Calcium Wiring Followed by Rotational Atherectomy and Subsequent Drug‐Coated Balloon Treatment for Femoropopliteal Artery Calcified Lesions
por: Yasunari Sakamoto, et al.
Publicado: (2025)

Drug‐Coated Balloon‐Based Treatment of Left Main True Bifurcation Lesion
por: Ae‐Young Her, et al.
Publicado: (2025)

Long‐Term Clinical Outcomes of Drug‐Coated Balloon Following Directional Coronary Atherectomy for Bifurcated or Ostial Lesions in the DCA/DCB Registry
por: Shunsuke Kitani, et al.
Publicado: (2024)

Drug‐Coated Balloon Treatment for LAD CTO in a Young Woman With Moyamoya Disease Guided by Intravascular Imaging
por: Shuangliang Ma, et al.
Publicado: (2024)

Enhanced Efficiency of Sequential Cutting Balloon Angioplasty in Calcified Coronary Artery Disease: The RODIN‐CUT Technique
por: Claudiu Ungureanu, et al.
Publicado: (2025)

The Vascular Response After Balloon Angioplasty of Infrapopliteal Intermediate Stenosis Evaluated by Optical Frequency Domain Imaging
por: Haruya Yamane, et al.
Publicado: (2024)

Twenty Years of Experience in One Thousand De‐Novo Left Main Coronary Angioplasty With Angiographic Control in a High‐Volume Centre Without On‐Site Cardiac Surgery
por: Alfonso Franzé, et al.
Publicado: (2025)

Application of Drug‐Coated Balloons in Complex High Risk and Indicated Percutaneous Coronary Interventions
por: Yvemarie B. O. Somsen, et al.
Publicado: (2024)

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Patients With High‐Bleeding Risk
por: Eun‐Seok Shin, et al.
Publicado: (2026)

A Comparison of a Drug Coated Balloon With Drug Eluting Stent Strategy for Treating Coronary Bifurcation Lesions
por: Natasha Corballis, et al.
Publicado: (2025)

Impact of the Balloon Pulmonary Angioplasty on the Diagnosis of Chronic Thromboembolic Pulmonary Hypertension: From the COMMAND VTE Registry‐2
por: Tatsunori Noto, et al.
Publicado: (2025)

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease
por: Eun‐Seok Shin, et al.
Publicado: (2025)

Absolute Coronary Flow Reduction Mediated by Microvascular Resistance in Myocardial Infarction: The FLOVITA Study
por: Benoit Guillon, et al.
Publicado: (2025)

Impact of Calcium Fracture After Balloon Angioplasty in Patients With Complex Calcified Coronary Plaque ~The Results of the OCT‐CALC Registry~
por: Nobuhiko Maejima, et al.
Publicado: (2025)

Comparison of Oxidative Stress Effects Between Drug‐Eluting Stents and Drug‐Coated Balloons: Insights Into Vascular Response and Clinical Implications
por: Muzaffer Aslan, et al.
Publicado: (2025)

Drug Coated Balloon in Young Patients With ST‐Elevation Myocardial Infarction: A Viable Treatment Option?
por: Davor Vukadinović, et al.
Publicado: (2025)

Predictors of Variability in Coronary Flow Reserve and Microvascular Resistance Measurement Using the Bolus Thermodilution Technique
por: Jason Galo, et al.
Publicado: (2025)

Clinical Outcomes of Intravascular Brachytherapy for Recurrent In‐Stent Restenosis: Is Treatment Failure Predictable?
por: Gal Sella, et al.
Publicado: (2025)

Real‐World Safety and Complications of the Boston Scientific AGENT Drug‐Coated Balloon From the FDA MAUDE Database
por: Sant Kumar, et al.
Publicado: (2025)

Drug‐Coated Balloons in Chronic Total Occlusion Percutaneous Coronary Intervention: Insights From the PROGRESS‐CTO Registry
por: Deniz Mutlu, et al.
Publicado: (2025)

Drug‐Coated Balloons Versus Drug‐Eluting Stents for De Novo Ostial Left Circumflex Lesions: The International Multicenter DCB‐CIRCO Registry
por: Francesco Tartaglia, et al.
Publicado: (2025)

Cardiovascular Outcomes of Drug‐Coated Balloon Versus Drug‐Eluting Stents for Femoropopliteal Peripheral Arterial Disease Interventions: A Meta‐Regression Analysis
por: Yasar Sattar, et al.
Publicado: (2026)

Commentary on “Infarct‐Related Myocardial Resistance Before Reperfusion to Predict Microvascular Injury and Clinical Outcomes”
por: Hussnain Bilal, et al.
Publicado: (2025)

Development and Internal Validation of a Four‐Predictor Nomogram for In‐Stent Restenosis After Drug‐Eluting Stent Implantation in Patients With Overweight/Obesity
por: Guo‐Biao Li, et al.
Publicado: (2025)